Raymond James analyst Michael Freeman lowered the firm’s price target on Healwell AI (HWAIF) to C$2.50 from C$3 and keeps an Outperform rating on the shares.
Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on HWAIF:
- Healwell AI price target lowered to C$2.50 from C$3.10 at Stifel
- HEALWELL AI: Buy Rating Backed by Profitable Shift to High‑Margin AI/SaaS and Strong Earnings Momentum
- HEALWELL AI Posts Record Revenue and Turns Adjusted EBITDA Positive as It Becomes Pure-Play AI Software Firm
- MCI Onehealth Technologies, Inc. Class A (AIDX) Q4 Earnings Cheat Sheet
- Healwell AI price target lowered to C$3.10 from C$3.80 at Stifel